2 Glorious Growth Stocks to Buy During the Latest Tech Sell-Off

The article argues that the recent 7.5% pullback in the Nasdaq Composite and AI-infrastructure selloff may be creating long-term opportunities, especially in Meta Platforms and Lemonade. Meta reported $56.3 billion in Q1 2026 revenue, up 33% year over year, and trades at a 21.3 P/E versus 35.3 for the Nasdaq-100, though it plans to spend up to $145 billion on AI data centers in 2026. Lemonade posted 3.1 million policyholders and $1.3 billion in in-force premium, both up 23% and 32%, respectively, with consensus 2027 revenue seen at $1.6 billion versus $738 million in 2025.

Analysis

The market is starting to question whether the AI capex trade is becoming self-defeating: the first-order winners from infrastructure spend have already rerated, while the second-order beneficiaries are the firms that can convert AI into either higher engagement or lower operating cost. META fits the former camp: if management even hints at moderating data-center spend, the stock can rerate on the dual narrative of higher free cash flow and better capital discipline, which matters more than incremental model improvements at this valuation. The real setup is that META’s downside is increasingly tied to sentiment around capex intensity, not fundamentals of ad demand, which gives the stock a cleaner asymmetry than the AI hardware complex.

LMND is a different kind of AI trade: it is no longer a story stock, but a unit-economics story. The key second-order effect is labor leverage — every point of automation improvement reduces the need for claims/service headcount, so operating leverage can expand faster than headline premium growth. That said, insurance winners usually get exposed to the first real loss-cycle; if reserving or loss ratio trends wobble, the market will punish the multiple long before revenue growth slows, because the current valuation already discounts a multi-year execution run.

The contrarian read is that the recent pullback in tech may be less about “AI fatigue” and more about positioning unwind in the most crowded beneficiaries. That favors selective longs in quality cash generators over outright beta: META can absorb a capex pause, while LMND remains a high-beta call option on sustained underwriting execution. The near-term catalyst path is mixed over days, but over 3-6 months the key variables are capital discipline at META and combined ratio stability at LMND; either one breaking favorably can force a sharp rerating, while either slipping will quickly compress multiples.

Key Decisions for Investors

• Go long META on weakness over the next 1-4 weeks; use a stop below the recent correction low. Risk/reward favors a rerating if management signals any moderation in 2026 AI capex or if ad growth stays >25%, since the stock can reprice on FCF, not just earnings.
• Initiate a small long LMND position only as a barbell growth sleeve, sized for volatility. Time horizon 6-12 months; attractive if premium growth remains >25% and the market continues to reward automation leverage, but cut exposure fast if loss ratios or reserve commentary deteriorate.
• Pair trade: long META / short a basket of high-multiple AI infrastructure beneficiaries. This expresses the view that spend discipline will matter more than top-line capex growth and reduces exposure to a broader AI hardware de-rating.
• For more tactical exposure, buy META call spreads 3-6 months out rather than stock. The catalyst is a possible sentiment pivot around capex guidance, and options cap downside if the market keeps punishing AI spend names.
• Avoid chasing NVDA/INTC on this headline; the article’s setup is a rotation away from crowded infrastructure winners. If the AI spend narrative weakens further, their multiple support is more fragile than META’s.